In June 2024, the U.S. Food and Drug Administration (FDA) approved Sofdra™ (sofpironium bromide) topical gel, 12.45% for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback